celecoxib has been researched along with Kidney, Polycystic in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Autosomal dominant polycystic kidney disease (ADPKD) is a progressive chronic kidney disease." | 5.38 | Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. ( Fu, LL; Mei, CL; Wang, NS; Xu, T; Ye, CY; Yu, SQ, 2012) |
| "Autosomal dominant polycystic kidney disease (ADPKD) is a progressive chronic kidney disease." | 1.38 | Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. ( Fu, LL; Mei, CL; Wang, NS; Xu, T; Ye, CY; Yu, SQ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, T | 1 |
| Wang, NS | 1 |
| Fu, LL | 1 |
| Ye, CY | 1 |
| Yu, SQ | 1 |
| Mei, CL | 1 |
1 other study available for celecoxib and Kidney, Polycystic
| Article | Year |
|---|---|
Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Celecoxib; Cell Cycle Checkpoints; Cell P | 2012 |